Harness the Power of Plasma to Combat C. diff
Clostridium Difficile (C. diff) Infections can be fatal and cause a significant burden on healthcare facilities across Europe. Patients who contract CDI spend on average an additional 2-3 weeks in hospital.
Research shows clear evidence of airborne dissemination of C. diff spores. This may help to explain why C. diff is so persistent within hospitals and difficult to eradicate.
Europe estimates suggest that the potential costs associated with the management of C. diff infections are in the region of €3,000 million ($3.3 B). This figure is likely to rise with an aging population. By 2050, 134 million Europeans will be 65 years or older.
Treating C. diff Costs €4,067 to €9,276 per Patient ($4400 - $10k)
A German study reported that the additional cost of treating C. diff per patient episode was €4,067 to €9,276 ($4400 – $10k).
Source: Journal of Hospital Infection 07/2008
50% Chance of Infection
A patient who inhabits a room after a previous patient who had C. diff, has a 50% increase in the likelihood of contracting C.diff themselves.
Source: Infect Control Hosp Epidemiology. 2011